• ESGold Corp. is connecting with Canadian and Quebec governments for potential non-dilutive funding to support its Montauban Project.
• The company is targeting near-term gold and silver production while focusing on sustainable mining practices.
• ESGold plans to create 20 to 30 new direct jobs and additional contract employment through exploration activities.
• Investment into clean technology and proprietary mining methods is a key part of the company’s growth strategy.
• ESGold shares offer an affordable way for investors to gain exposure to gold amid historically high commodity prices.

ESGold (CSE: ESAU) (OTCQB: ESAUF) is moving closer to gold and silver production at its Montauban Project in Quebec, with the company now actively exploring funding partnerships with both provincial and federal governments. The focus of these discussions is to secure non-dilutive support that aligns with broader goals of sustainability, innovation, and regional job creation, according to a company press release (https://ibn.fm/cBRI3).

The Montauban Project covers 265 mining claims across 13,116 hectares and is fully permitted for construction. ESGold has begun developing a 500-tonne pilot plant and plans to scale up to a 1,000-tonne commercial facility, with first gold and silver production expected later this year. The company’s collaborative approach with government stakeholders reflects an effort to align with Quebec’s clean industry initiatives and Canada’s economic diversification goals.

Discussions with government entities include potential support for construction, equipment acquisition, and continued technological innovation. These partnerships, if finalized, would provide ESGold with non-dilutive capital—allowing the company to finance key growth initiatives without increasing shareholder dilution.

Job creation is central to the Montauban Project’s anticipated impact. ESGold expects to generate between 20 and 30 new direct jobs during its production phase, while exploration drilling across its land package will drive additional contract employment for drill operators, geologists, and lab technicians. By prioritizing local hiring and contractor use, the company aims to deliver tangible economic benefits to the region.

Environmental stewardship is another pillar of ESGold’s development plan. The company is investing in high-performance equipment and developing proprietary technologies designed to minimize environmental impact and optimize operational efficiency. These measures are intended to position ESGold as a participant in the broader movement toward cleaner, more responsible mining practices.

Exploration work remains an important part of ESGold’s long-term strategy. Expanding the resource base at Montauban through additional drilling could extend the life of the mine and increase production potential. In turn, this could enhance the company’s valuation and further differentiate ESGold from other junior miners seeking to move into production.

Importantly, ESGold offers investors a relatively low-cost entry point into the gold sector at a time when gold prices remain high. Unlike purchasing physical gold, which ties investors directly to current commodity prices, ESGold shares offer exposure to the potential upside of new production at a project that is fully permitted and already under construction. This structure could provide greater return potential if gold prices rise further or if ESGold successfully ramps up production in 2025.

Brad Kitchen, President of ESGold, emphasized that the company’s goal is to create lasting value for both shareholders and the communities where it operates. “By engaging in meaningful collaboration with government stakeholders, we aim to position Montauban as a model of clean resource development and economic revitalization,” Kitchen said.

For more information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Nightfood is driving change through technology-enabled solutions that are reshaping how the hospitality sector operates and connects with guests
• NGTF offers cutting-edge Robotics-as-a-Service (“RaaS”) solutions that address service challenges head-on
• The company is also pursuing strategic hotel acquisitions to serve as real-world showcases for its hospitality tech

The hospitality industry has undergone a major transformation. As travel increases and guest expectations evolve, hoteliers are under more pressure than ever to deliver personalized, seamless and proactive service — all while managing rising costs and operational complexity. This dynamic environment calls for innovation not only to stay competitive but to thrive before smart technology becomes a standard within all hospitality businesses. Nightfood Holdings (OTCQB: NGTF), a forward-thinking holding company, is emerging as a key player driving this change through technology-enabled solutions that are reshaping how the hospitality sector operates in this modernized world.

One of the most pressing challenges in hospitality today is the widening gap between demand for service and available labor. According to the American Hotel & Lodging Association (“AHLA”), more than 80% of hotels are facing staffing shortages, with housekeeping being the most critical area (https://ibn.fm/bKAOE). At the same time, guest expectations have never been higher. Travelers expect real-time responses, personalized experiences and consistent service—whether they’re staying at a five-star resort or a mid-range city hotel. Traditional systems simply can’t keep up.

This is where Nightfood Holdings steps in. Through its wholly owned subsidiary Skytech, NGTF offers cutting-edge Robotics-as-a-Service (“RaaS”) solutions that address these challenges head-on. These innovative solutions aren’t gimmicky tech upgrades — they’re transformative tools that are attacking real world problems, giving businesses and the staff great returns with Skytech’s unique capabilities (https://ibn.fm/CEvaK).

To continue, NGTF’s operating company, Future Hospitality Ventures,  includes service robots and smart automation tools that perform everything from food delivery to front-desk concierge functions (https://ibn.fm/d6Hqp). But it’s the integration of predictive analytics and intuitive robotics that makes these solutions truly powerful. By analyzing guest behavior and leveraging machine learning, these technologies help hotel teams anticipate needs before they arise. For example, if a frequent traveler prefers a certain room temperature or requests extra towels during previous stays, the system can accommodate those preferences without the guest ever having to ask. This shift from reactive to proactive service is more than just a technological advancement, it’s a new hospitality paradigm.

Important to note, NGTF is pursuing strategic hotel acquisitions to serve as real-world showcases for its hospitality tech. A recent $41 million letter of intent to acquire a Victorville, California, property underscores this approach (https://ibn.fm/iEfc7). The company plans to transform this hotel into a flagship model for robotics-enabled hospitality, demonstrating the ROI of automation in real time. These initiatives are designed to accelerate revenue, create cost savings and validate the effectiveness of Nightfood’s RaaS offerings across diverse hospitality environments 

The market potential for this innovation is significant. The global hospitality robotics market is projected to reach $65.4 billion by 2032, driven by increased demand for operational automation and service personalization (https://ibn.fm/LCPZS). As one of the few publicly traded companies uniquely positioned at the intersection of hospitality and AI, NGTF stands to offer a compelling investment opportunity for forward-looking stakeholders.

Nightfood Holdings is clearly not just another tech vendor or service provider — it’s a catalyst for the next era of hospitality. By combining intelligent automation with a human-centric vision, NGTF is helping hotels adapt to modern demands while staying true to the core of hospitality. investors seeking a foothold in the future of this evolving industry before it’s too late, Nightfood Holdings is truly a win-win scenario.

For more information, visit the company’s website at NightfoodHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• “Research on the treatment of cancer is fundamental to improving outcomes for all patients affected by the disease,” reports the National Cancer Institute.
• CLDI is reporting preclinical results for its systemic RTNova platform, which has successfully delivered transient gene therapy payloads to targeted tumors.
• “With this breakthrough, we can use our platform to develop multiple assets for various indications,” says CEO.

Cancer remains one of the most formidable health challenges worldwide, necessitating relentless research to uncover effective treatments. Continuous scientific inquiry has led to groundbreaking therapies, offering hope to millions. A recent development in this arena is Calidi Biotherapeutics’ (NYSE American: CLDI) announcement of promising preclinical results for its systemic RTNova platform, highlighting the critical role of research in combating cancer.

The significance of research in cancer treatment cannot be overstated. Through dedicated efforts, scientists have deepened our understanding of cancer biology, leading to the development of targeted therapies that attack specific molecular abnormalities in cancer cells. This precision medicine approach has revolutionized treatment protocols, resulting in therapies that are more effective and less harmful to healthy tissues.

“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected by the disease,” states the National Cancer Institute (https://ibn.fm/LO44e). “Treatment advances, in combination with innovative diagnostic tools, are leading to therapies that are increasingly tailored to the cancer’s unique traits.”

Clinical trials are integral to translating research discoveries into clinical applications. These trials rigorously evaluate the safety and efficacy of new treatments, ensuring that only those with proven benefits reach patients. Participation in clinical trials not only provides patients with access to cutting-edge therapies but also contributes to the collective understanding of cancer treatment, paving the way for future innovations.

Calidi Biotherapeutics, a clinical-stage biotechnology company, exemplifies the fruits of rigorous research in its recent announcement (https://ibn.fm/F71fk). The company is reporting promising preclinical results for its systemic RTNova platform, which has successfully delivered transient gene-therapy payloads to targeted tumors. Additionally, Calidi’s tumor-specific virotherapy demonstrated efficacy in killing more than 60 different tumor cell lines, showcasing the platform’s potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation.

“Targeting tumors with a systemic virotherapy with a multimodal mechanism of action, which includes direct killing of the tumors and robust activation of antitumor immune responses, may revolutionize the way we approach cancer treatments,” said a Calidi spokesman. “We are excited to have shown that our systemic platform can act also as a viral vector to express therapeutic genes in target tumors, which will maximize the potential of the designed treatment. With this breakthrough, we can use our platform to develop multiple assets for various indications, opening the door for potential partnership opportunities.”

The RTNova platform addresses significant challenges in treating advanced-stage metastatic cancers, such as lung cancer, where direct tumor injection is not feasible. Calidi has engineered a novel vaccinia virus strain enveloped with a human cell membrane, known as an extracellular enveloped virus (“EEV”). This design provides protection in the bloodstream while targeting distant tumors. Upon reaching the tumor, the virotherapy selectively replicates and destroys tumor cells, inducing an immune response that trains the immune system to recognize and target future cancer cells. Furthermore, the platform’s ability to target distant tumors allows it to act as a viral vector, delivering specific gene therapies directly to tumor sites.

Research serves as the backbone of progress in cancer treatment, leading to the development of innovative therapies that improve patient outcomes. Calidi Biotherapeutics’ recent preclinical success with the RTNova platform exemplifies how dedicated research can yield promising new treatment avenues, reinforcing the vital importance of continued investment in cancer research.

Calidi Biotherapeutics is committed to advancing the RTNova platform into clinical development, aiming to provide a novel therapeutic option for patients with metastatic cancers. The company’s mission centers on leveraging cutting-edge research to develop targeted immunotherapies that address unmet medical needs in oncology. By focusing on innovative approaches like the RTNova platform, Calidi strives to transform the landscape of cancer treatment, offering new hope to patients worldwide.

For more information, visit www.CalidiBio.com.

NOTE TO INVESTORS: The latest news and updates relating to CLDI are available in the company’s newsroom at https://ibn.fm/CLDI

• Report notes that the increasing pace of transactions serves as an encouraging sign for the hospitality industry
• Nightfood Holdings has closed on two acquisitions this month alone
• Company is “building a powerful ecosystem designed to lead the future of hotel automation,” says chair

Strategic acquisitions are a cornerstone for companies aiming to scale and diversify, particularly in the hospitality sector, where consumer preferences and technological advancements rapidly evolve. In this dynamic environment, Nightfood Holdings (OTCQB: NGTF) has demonstrated its commitment to savvy acquisitions in the past six months, positioning itself to capitalize on emerging robotic trends and broaden its market presence.

“The year 2024 marked a significant period of strategic consolidation within the hotel management industry, reflecting a deeper trend beyond mere financial transactions,” stated a recent ReportLinker article (https://ibn.fm/TZpQk). “These mergers and acquisitions (“M&A”) signal a substantial shift in the way hotel management companies are positioning themselves in an ever-evolving market landscape.”

“This increasing pace of transactions serves as an encouraging sign for the hospitality industry, suggesting not only a recovery from any past market slowdowns but also an optimistic outlook for the future,” the article continued. “The strategic nature of these mergers and acquisitions, focusing on scalability, market penetration and operational synergies, highlights a proactive approach to navigating the challenges and opportunities of the hospitality market.”

Nightfood Holdings’ recent acquisitions reflect this strategic approach. In September 2024, Nightfood completed the acquisition of CarryoutSupplies.com, a leading wholesaler and distributor of custom takeout packaging for the food-service industry (https://ibn.fm/N3UA3). This strategic all-stock acquisition expanded Nightfood’s product offerings and customer base, enhancing operational efficiencies and opening new avenues for cross-promotion within its subsidiaries.

“Acquiring Carryout Supplies is a major step forward in our strategy to transform hospitality operations,” said Jamie Steigerwald, chair of Nightfood Holdings. “Combining their industry-leading packaging capabilities with our advanced automation technology enables us to offer more efficient, scalable solutions that directly address cost, labor, and operational challenges in the sector.”

The company has closed on two additional acquisitions this month. On April 1, the company announced the successful acquisition of Skytech Automated Solutions Inc., a recognized expert in artificial intelligence (“AI”)-driven service technologies for the hotel industry (https://ibn.fm/joUNP). This acquisition enhances Nightfood Holdings’ Robots-as-a-service (“RaaS”) capabilities and accelerates market penetration across the hotel sector – with robotics being an inevitable evolution that forward-thinking businesses will need to embrace to lead in the future.

“Closing the Skytech acquisition represents a transformative leap forward for Nightfood,” said Steigerwald. “This strengthens our ability to scale automation across the hospitality industry-addressing key operational pain points such as labor shortages and rising costs. Together with the Carryout Supplies acquisition, we’re building a powerful ecosystem designed to lead the future of hotel automation.”

In addition, Nightfood has signed a letter of intent (“LOI”) to acquire the assets of Victorville Treasure Holdings LLC, owner and operator of a 155-room Holiday Inn(R) in Victorville, California (https://ibn.fm/BrIyb). This acquisition represents the company’s plan to become a leader in hotel ownership and management; Nightfood Holdings has developed more than 50 properties and manages more than 130 hotels.

The Victorville property is undergoing a major renovation, including the addition of a new state-of-the-art fitness center, to qualify for the Courtyard by Marriott(R) rebranding. Following the acquisition, Nightfood plans to continue developing the site as a model property and proof-of-concept for its integrated RaaS platform and hospitality asset management approach-one of many more to come.

“This transaction marks another milestone in Nightfood’s aggressive acquisition strategy, further expanding its footprint in hospitality real estate and smart-service automation,” the company observed. “The Victorville property utilizes Skytech’s robotic technologies to reduce operating costs and improve profitability.

Through these strategic acquisitions, Nightfood Holdings is not only expanding its operational capabilities but also reinforcing its position as a leader in the transition to a more modern and efficient hospitality sector as well as hotel management. By identifying and integrating complementary businesses, the company is poised to enhance its market position and deliver value to stakeholders.

For more information, visit the company’s website at NightfoodHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs, just recorded the highest home attendance of the season for its S.S. Juve Stabia S.r.l football club competing in Italy’s Serie B
• The derby match against Salernitana, held on April 5, posted a crowd of 7,000 fans at Stadio Romeo Menti in Castellammare di Stabia, just 100 shy of a full sell-out
• For Brera, this milestone pointed to the club’s potential, along with its trajectory to become a playoff-competitive football club and a globally relevant brand
• It also affirmed the company’s continued push for matchday monetization, a key priority for its revenue-generation activities for the 2025-26 season

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, just recorded the highest home attendance of the season for its S.S. Juve Stabia S.r.l football club, “The Second Team of Naples,” a significant milestone for the company. Its management continues to push for matchday monetization, a key driver for the 2025-26 season revenue-generation (https://ibn.fm/yILdD).

On April 5, in a match against Salernitana, Juve Stabia posted a crowd of 7,000 fans, just 100 seats shy of a full sell-out given the stadium’s 7,100 capacity. For the club, this attendance not only delivered a vibrant atmosphere but also showed passion for the game, which was a huge morale boost for the team.

“The turnout wasn’t just a show of passion – it was a tangible step forward in our matchday revenue strategy,” noted Brera’s Executive Chairman, Daniel McClory. “Our goal is to build a commercially sustainable club, and that starts with maximizing our stadium potential and deepening the connection with our supporters,” he added (https://ibn.fm/yILdD).

For Brera, this was a major milestone followed by the recent international broadcast that saw Juve Stabia’s match against Cremonese aired live across the U.S., U.K., and Canada. It is part of a deliberate move to grow the Juve Stabia name internationally, with appeal to an international audience, and to continually build its revenue streams.

“This international spotlight reflects the rising trajectory of Juve Stabia as both a competitive football club and a globally relevant brand,” noted Mr. McClory. “We are proud to see the club’s identity resonate beyond Italy, and we welcome new fans from around the world who are discovering the energy and ambition of this team, along with the devoted diaspora of Italians abroad who cheer for Le Vespe every match,” he added (https://ibn.fm/6mmTX).

Juve Stabia ranks 5th in Italy’s Serie B league, and its off-field value has consistently expanded in the past few months. Since mid-March, it has achieved the highest value increase in the league at €16.13 million, representing a 36.19% growth, according to Transfermarkt. As an overall commercial strategy, Brera has molded Juve Stabia to complement its sporting ambitions, with potential investments in infrastructure, ticketing, and fan experience all supporting long-term growth (https://ibn.fm/yILdD).

For Brera, these milestones point to the club’s potential. They also point to its diligence in identifying the right investment opportunities, seeing as the company is on track to owning a majority stake in S.S. Juve Stabia. Since signing the initial Letter of Intent in December 2024, Brera and Juve Stabia have made some incredible strides, which only speaks to more achievements yet to come. Brera’s management remains optimistic and confident that the club will continue to grow both in revenue and rankings, as will its global reach and impact.

“We’re encouraged by the traction and remain focused on building a strong commercial foundation for Juve Stabia’s continued ascent,” concluded Mr. McClory (https://ibn.fm/yILdD).

For company information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• D-Wave and Japan Tobacco’s pharmaceutical division completed a proof-of-concept project aimed at speeding up and improving the design of small molecule pharmaceuticals. 
• D-Wave’s annealing quantum computer was used to train large language models within Japan Tobacco’s AI framework.
• The quantum-hybrid application outperformed classical methods in generating valid and drug-like molecules.
• Japan Tobacco plans to further pursue Quantum AI in molecular design following these early results.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT”), have announced the successful completion of a proof-of-concept project applying quantum computing and artificial intelligence (“AI”) to drug discovery. The project demonstrated that a hybrid quantum-classical system outperformed classical methods in generating potential drug compounds (https://ibn.fm/5sTUn).

The project used D-Wave’s annealing quantum computer to enhance the training of large language models (“LLMs”) for chemical structure generation. LLMs, which are foundational to modern generative AI, were integrated into JT’s drug discovery process to explore chemical space and propose novel molecular structures. The hybrid quantum approach produced a higher proportion of valid, drug-like molecules compared to classical-only models.

The generated compounds displayed a higher quantitative estimate of “drug-likeness” than the molecules in the training data or those produced through classical LLM training. This suggests that annealing quantum computing may help optimize low-energy molecular configurations more effectively than conventional computing alone.

The collaboration focused on first-in-class small molecule pharmaceuticals. The use of quantum computing in training the AI models appears to have improved both the diversity and the quality of generated molecular structures, a key objective in early-stage drug development.

Dr. Masaru Tateno, Chief Scientific Officer at JT’s Central Pharmaceutical Research Institute, said the team used D-Wave’s annealing quantum computer to shift the AI-generated compounds toward a more “drug-like” molecular ensemble—without explicitly programming the models to do so. “To the best of our knowledge, this is the first work for annealing quantum computation to outperform classical results concerning LLM training in drug discovery,” Dr. Tateno added. “This validation has also revealed that annealing quantum computing systems can deliver high quality, low energy samples that could drive enhanced performance in generative AI architectures.”

JT has indicated plans to continue developing its capabilities in this area, with the goal of using quantum computing for real-world molecular design applications. “Moving forward, with D-Wave’s quantum annealing machines, we aim to maximize the use of quantum computing hardware characteristics and accelerate our efforts in achieving Quantum AI-driven drug discovery,” Dr. Tateno said.

While generative AI has rapidly progressed in life sciences applications, the computational requirements are growing. As model complexity increases, power consumption and costs become limiting factors, said D-Wave CEO Dr. Alan Baratz, noting that quantum computing may offer a more energy-efficient and scalable way to train these models, potentially enabling broader use of AI in industries like pharmaceuticals.

“We believe that our work with JT is an important demonstration and validation of quantum’s integration with AI. When used together, these powerful technologies can help customers build more efficient, rapid, and energy-saving AI and machine learning workloads,” Dr. Baratz added. “While we are just at the beginning of exploring Quantum AI’s potential impact, in our view, this work is a resounding step forward.”

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our 5,000+ qubit Advantage(TM) quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our Advantage and Advantage2(TM) systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

• Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive transition to value-based care.
• The company’s patented analytics engine predicts revenue performance and simplifies contract reimbursement analysis to maximize financial efficiency.
• Adageis acts as an advocate for providers, helping them understand what payments they should expect from insurers.
• The platform integrates with over 90 EHR systems and supports providers through improved cash flow and access to funding.
• With growing adoption, Adageis continues to expand investor partnerships and develop superior tools for smaller healthcare practices.

Adageis, a forward-thinking healthcare technology company, has a comprehensive suite of AI-powered solutions aimed at providers shifting from fee-for-service to value-based care. With growing policy support and payer incentives, value-based care has become a pressing priority across U.S. healthcare systems. But many providers—especially smaller ones—lack the tools to navigate this transition efficiently and profitably. Adageis makes it all possible.

At the core of the company’s offering is its ProActive Care Platform, which combines predictive analytics with real-time data integration to improve both clinical and financial outcomes. The platform’s Patented Risk Engine (“PRE”) enables users to forecast revenue based on quality performance metrics and patient care patterns. For providers managing contracts that tie compensation to outcomes, these insights are increasingly important.

One area where Adageis stands out is its ability to help clients advocate for themselves with insurers. As the complexity of payer agreements grows, many providers are unsure of what they’re actually owed. Adageis uses its platform to analyze contract terms, performance metrics, and historical claims data, to tell providers what payments they should be receiving—and where they may be falling short.

This approach positions Adageis not just as a service provider, but as an advocate. By delivering insight into financial performance and payer compliance, the company enables providers to push back against underpayments and negotiate from a position of strength.

The company’s platform is already serving 70 providers and covering over 260,000 patient lives. It has been integrated with more than 90 electronic health record (“EHR”) systems, including platforms like Epic, AthenaHealth, Cerner, and eClinicalWorks. This broad interoperability is essential to the company’s strategy of scaling rapidly across provider types and geographies.

A key benefit for providers is improved cash flow predictability. By using AI to model expected payments from accountable care organizations (“ACOs”), independent physician associations (“IPAs”), clinically integrated networks (“CINs”), and insurers, Adageis helps providers better manage their revenue cycles. For some clients, this has translated into as much as $75,000 in additional annual value-based care revenue.

The company is preparing for a significant expansion by the end of Q2 2025. It anticipates reaching 580,000 covered lives, generating $100,000 in monthly recurring revenue, and onboarding two to three new clients each month. As part of this growth strategy, Adageis has reduced its implementation time to just one week, a shift that could help smaller practices adopt its technology without major operational disruption.

Looking ahead, Adageis is collaborating with investors to develop additional tools for small and independent practices. These offerings are expected to focus on lowering onboarding costs, expanding financial access, and simplifying value-based care participation for providers without in-house administrative infrastructure.

In a healthcare landscape where policy and payer structures are evolving quickly, Adageis is betting that data-driven advocacy and financial insight will become essential for survival—particularly for providers serving complex or underserved populations. For investors seeking to enter the healthcare technology space, the company’s combination of AI, finance, and operational support represents a one-of-a-kind approach within a crowded field.

For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

• On April 13, a match between SS Juve Stabia S.r.l and Cremonese was aired live with English-language commentary in the U.S., Canada, and the U.K. through Destination Calcio. Juve Stabia is a portfolio club of Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs
• The broadcast marked a key milestone for the club and the company in growing their global recognition and key English-speaking markets
• Brera is optimistic that initiatives such as these will expand the club’s footprint beyond Italy, ultimately reaching a broader base of international supporters
• In addition, its management is confident that it will further showcase the energy and ambition of the team to new audiences, including Italians living abroad

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on building a global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) model, announced that on April 13, 2025, its portfolio club SS Juve Stabia S.r.l.’s match against Cremonese was broadcast live in the United States, Canada, and the United Kingdom. This broadcast was conducted in partnership with Destination Calcio, with full English commentary, marking a key milestone for the club and the company in growing global recognition (https://ibn.fm/9PTJw).

The match was hosted by fourth-ranked Cremonese, and Juve Stabia played to a 1-1 draw. SS Juve Stabia currently ranks 5^th in Serie B and recently made headlines for achieving the highest squad value growth in the league at 36.8% since mid-March. The club has also posted a recent season-high home attendance of 7,000 fans at Stadio Romeo Menti in Castellammare di Stabia in its match versus Salernitana, signifying the club’s growing popularity fast extending beyond Italy.

“This international spotlight reflects the rising trajectory of Juve Stabia as both a competitive football club and a globally relevant brand,” noted Daniel McClory, Executive Chairman of Brera Holdings (https://ibn.fm/9PTJw).

Live, English-language broadcasts such as these look to present SS Juve Stabia to an even bigger audience, specifically those in the U.S. with a growing appetite for authentic European football. Serie B promises intense competition with a rich pipeline of emerging talent, which SS Juve Stabia offers. The reception it is getting is encouraging not just to the players but also to Brera’s shareholders, the club’s fans, and the surrounding community.

“We are proud to see the club’s identity resonate beyond Italy, and we welcome new fans from around the world who are discovering the energy and ambition of this team, along with the devoted diaspora of Italians living abroad who cheer for ‘Le Vespe’ every match,” added McClory (https://ibn.fm/9PTJw).

Brera owns 38.46% of Juve Stabia and is on track to own a majority stake in the club. Its interest in owning a controlling share started in 2024, with the initial steps toward the acquisition in December 2024. The first phase was concluded on Dec. 31, initially bringing the company’s ownership to 21.74%. The second was reached on Jan. 10, 2025, and brought Brera’s interest to 34.62%. On Feb. 12, 2025, Brera announced the third closing in its multi-step transaction, bringing its equity ownership up to 38.46%. (https://ibn.fm/7FQEI). Brera has since been successfully reviewed by the Italian Football Federation (“FIGC”) on the acquisition, confirming that it satisfied the standards of financial soundness and reputational integrity required by the set regulations (https://ibn.fm/qukQ6).

Brera is optimistic that with partnerships and initiatives like this with Destination Calcio, SS Juve Stabia will expand its footprint beyond Italy, ultimately reaching a broader base of international supporters. The potential is endless, particularly given the club’s potential to be promoted to Serie A, a move that will further stamp its position as the club to watch. The company’s management remains optimistic and looks to assure fans and shareholders that there will be more initiatives such as these going forward.

For company information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

The Vermont Cannabis & Hemp Convention is set to take place on May 2-3, 2025, at the Champlain Valley Expo in Burlington, VT. This NECANN event puts special emphasis on Vermont’s local cannabis industry. Focusing exclusively on the local cannabis community, NECANN strives to help industry players achieve a more significant ROI. The convention brings together industry leaders, experts, and entrepreneurs to explore the latest developments and opportunities in the cannabis and hemp sectors.

Why Attend? 

• Over 100 exhibitors will showcase their cutting-edge products, services, and innovations to a crowd comprising leading experts in the cannabis industry.
• The event will feature expert speakers and workshops covering topics such as medical marijuana, industrial hemp, CBD wellness products, and the latest trends in the New England cannabis industry.
• The event provides a platform for attendees to connect with industry professionals, investors, and like-minded individuals, fostering potential business partnerships and collaborations.
• Stay up-to-date on industry trends and learn about the latest tools and resources to stay ahead of competitors.
• Network with industry leaders and connect with entrepreneurs to explore new business collaborations.
• Gain valuable insights from expert speakers during keynote sessions and panel discussions and get all queries solved by the experts.

The Vermont Cannabis & Hemp Convention is the largest event focused on the Vermont cannabis industry, benefitting a broad spectrum of industries, namely business owners, investors, professionals, and enthusiasts. The NECANN event offers a curated agenda backed by a well-researched program. New and established players in the cannabis sector can showcase their products and innovations at the exhibition hall. With robust networking opportunities, this event is poised to drive growth in the Vermont cannabis industry.

To know more, please visit https://ibn.fm/n019x.

• Despite policy uncertainty, demand for scalable solar and storage solutions in North America remains strong, especially in commercial and community sectors, the Zacks report says.
• The company has a development pipeline exceeding 1 GW and is aiming to triple its owned capacity in the next two years.
• SolarBank is expanding from solar EPC services into independent power production (“IPP”) and battery energy storage systems (“BESS”).

Disseminated on behalf of SolarBank Corporation

Zacks Small-Cap Research has launched coverage of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S. (https://ibn.fm/lYkSZ). The Zacks report highlights SolarBank’s growing role as an integrated energy firm with a strategy focused on building out its independent power production (“IPP”) capabilities and battery energy storage systems (“BESS”) to meet rising electricity demand in North America.

SolarBank is transitioning from an engineering, procurement, and construction (“EPC”) provider to owning and operating more of its own solar and storage assets. This shift is expected to improve revenue consistency and margins over time. The company is currently managing a project pipeline that exceeds 1 gigawatt (“GW”) and has already completed installations totaling more than 200 megawatts (“MW”), according to the Zacks report (https://ibn.fm/XBhNS).

Currently, SolarBank has approximately 25 MWp of solar and 60 MWh of storage under construction, with another 149 MWp in late-stage development. Over the next 24 months, the company expects to triple its owned solar and storage capacity. This growth is being driven by both private-sector demand and the need for energy systems that can be quickly deployed.

Zacks expects significant revenue growth for SolarBank in FY2025 and FY2026. This projection is supported by contracts with Qcells and Honeywell and an expanding backlog of IPP and BESS projects. The battery energy storage segment, in particular, is emerging as a critical piece of North America’s energy infrastructure. BESS is forecast to be the fastest-growing part of the energy sector through 2030, driven by the electrification of transportation, increasing data center demand, and grid stability needs. SolarBank’s involvement in this space positions it well to benefit from these trends.

Policy risk remains a factor. Although political developments have introduced uncertainty into federal renewable energy policy, potentially affecting incentives and regulatory frameworks, Zacks notes that the practical need for new energy infrastructure—especially in commercial, industrial, and community-scale solar—will likely continue to drive demand regardless of political developments.

SolarBank’s share price has seen volatility in recent months, influenced by macro policy signals and recent below-market financing. However, the Zacks report suggests that the company’s fundamentals and strategic focus could offer upside for investors willing to navigate short-term market noise.

Investors interested in the renewable energy space may find SolarBank’s expanding IPP footprint and BESS focus to be compelling aspects of a longer-term growth story, particularly as utility-scale and commercial solar continue to outpace residential deployment. As the demand for scalable and reliable energy solutions rises, SolarBank’s role as both a developer and operator could position it to deliver more consistent returns in a sector known for volatility.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “SolarBank Announces 2024 Highlights” for additional details on the statements, risks and assumptions. The target price and revenue forecasts in the report are based on Zacks analysis and the company has not provided guidance to Zacks on this matter. While SolarBank paid Zacks a fee to complete the report, the report was based on Zacks analysis.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN